Onyx Pharmaceuticals to Present at the 27th Annual JPMorgan Healthcare Conference
Inc. (Nasdaq: ONXX) today announced that it will present at the 27th Annual
JPMorgan Healthcare Conference on
Time
website at: http://www.onyx-pharm.com/wt/page/event_calendar.
It is recommended that listeners log on 15 minutes early in order to
register and download any necessary software. For those unable to participate
during the live webcast, a recorded replay of the presentation will be
available within 24 hours of the completion of the presentation through
Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to
improving the lives of people with cancer by changing the way cancer is
treated(TM). The company, in collaboration with Bayer HealthCare
Pharmaceuticals, Inc., is developing and marketing Nexavar(R), a small
molecule drug. Nexavar is currently approved for the treatment of liver
cancer and advanced kidney cancer. Additionally, Nexavar is being
investigated in several ongoing trials in non-small cell lung cancer,
melanoma, breast cancer, and other cancers. For more information about Onyx,
visit the company’s website at http://www.onyx-pharm.com.
Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer
Pharmaceuticals Corporation.
SOURCE Onyx Pharmaceuticals, Inc.